Capture
PRODUCTS
-
Experienced CDMOs will implement a cGMP aseptic manufacturing and sterile fill-finish policy to improve drug bioavailability. Aseptic fill-finish is a process in which the drug product, container, and container closure are sterilized separately and then integrated. Combining the drug, container, and closure in a clean room using special equipment that is self-contained in a sterile environment meets FDA guidelines related to cGMP.
-
Traditional bioburden testing (or microbial limit testing) takes several days to grow visible colonies of microorganisms, so identifying these and initiating corrective action takes longer. The Milliflex® Quantum system quantitatively detects microbial contamination in filterable samples in as little as a third of the time it takes with traditional plate-based monitoring methods. The Milliflex® Quantum system is based on fluorescent staining of all viable microorganisms, making emerging microcolonies visible to the systemwhen they’re still too small to be seen with the naked eye. After rapid detection, the colonies can be reincubated to grow into visible colonies and be identified by any method—an approach that cleverly combines rapid and compendial bioburden testing.
-
Move your research forward with a versatile transfection reagent that is the solution for hard-to-transfection and common cell types. Proven and reliable, TransIT-X2® allows you to avoid guesswork and get it right the first time.
-
The new XR75 DualX X-Ray system can detect contaminants as small as 0.4mm and significantly improves detection of low-density or soft contaminants, such as bones in poultry and products with overlapping pieces in a pack or bag such as fries, frozen vegetables and chicken nuggets, among other food products.
-
If you were around the clinical trial industry in the late 2000s when Trial Interactive was born, you know the internal struggle of trying to digitize procedures. Most of us were still using Blackberrys or flip phones, and convincing management to abandon paper and move to an electronic document management system seemed daunting. Luckily, we don’t come across that struggle as often now.
Instead, we strive to simplify and modernize the processes we have in place. An interoperable, connected, and streamlined platform that can manage all aspects of a clinical trial has become mandatory. If last year showed us anything about our industry, it’s that the time to push electronic technology was five years ago. Now, we need to ensure all processes are able to run and can be accessed remotely as we make up for time lost.
The Trial Interactive 10.2 release presents another wave of technology seeking to push boundaries through machine learning (ML), artificial intelligence (AI), and making the unexpected the standard.
WHITE PAPERS AND CASE STUDIES
-
Developing A Multi-Drug Combination, Antiparasitic Drug For Dogs
Discover how it worked to manufacture clinical supplies of flavored tablets with multiple APIs in just six months while ensuring content uniformity and stability.
-
Vision Inspection And Checkweighing For Natural Food Processors
A family-owned business that produces a variety of fruit spreads made from all natural ingredients installs systems to ensure product accuracy, label printing for consumer knowledge, and tracking capabilities for their customers
-
Hybrid Protection Of Single-Use Bags, Bottles And Vials
Discover advantages in terms of cost-efficiency and reduced workforce through hybrid systems for protective single-use shell solutions around liquid transfers in biopharmaceutical manufacturing.
-
Nanosuspension Dosage Forms: Product Development & Scale Up
For drug nanosuspensions, parameters like stabilizer concentration, drug loading, milling speed, milling time, bead diameter/density, and temperature are important formulation and process variables.
-
Applying Variable Speed Compressors In Multiple Compressor Applications
Variable speed control for all types of industrial equipment is readily available on the market with competitive pricing to non-variable speed controlled alternatives, including in the air compressor industry. With the advent of prescriptive rebate programs for variable speed compressors and other equipment, the demand for these types of controls has increased.
-
Assessing A Platform for Accelerating Product Development
Examine an innovative approach to accelerating drug development, and learn the savings to drug developers from applying the approach across the industry portfolio of investigational drugs.
-
Why Form Follows Function For Cell Culture Science
Configurability builds cell culture equipment around processes, so you don’t need to build your processes around your equipment.
-
Precision Powder-In-Capsule Micro-Dosing Accelerates Drug Product Development
Precision powder microdosing makes it possible to quickly get formulations to the clinic, saving time, money, and use of limited APIs.
-
Switching Delivery Formats: A Lifecycle Management Strategy For Sterile Injectables
Switching delivery formats can be an effective strategy to enhance the lifecycle of your drug. Gain insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another.
-
Transforming From Supply-Led To A Demand-Led Model To Support Commercial Gene Therapies
In gene therapies supply chains, the focus is entirely patient-centric and the ‘volumes’ can often be as low as 1 dose per batch/lot, so the supply and distribution model needs to be much more flexible and precise.
-
Improving Field Operations Workflows
To simplify and modernize its processes for gathering and referencing underground telecommunications infrastructure, ADP Resources leveraged the power of a cloud-based GIS solution that includes a robust suite of mobile apps that support the gathering of the necessary field data that planning and design teams rely on to facilitate design and permitting tasks. With accurate and up-to-date information readily available across the organization, ADP Resources' ability to meet and exceed the needs of its customers was drastically improved.
-
Advantages Of Single-Use Bag-Independent Shell Solutions
With the implementation of a shell solution for their single-use bags, this CDMO managed to reduce its costs for cold chain logistics with single-use bags by more than 60%.
NEWS
-
Accelerating Tube Picking & Selection3/9/2022
The Mohawk tube selector and picker from Ziath employs a linear rack reader and ninety-six pins that allow a frozen or thawed sample tube to be raised when a rack is scanned according to a picklist.
-
BIXOLON Demonstrates Its Latest Range Of Innovative Logistics Solutions At LogiMAT 20225/25/2022
BIXOLON, the global manufacturer of advanced Receipt, Label and Mobile printers invites you to visit stand #6D11 at LogiMAT 2022, where it will be exhibiting its growing range of printing solutions dedicated to the intralogistics market.
-
Automated Barcode Applicator For Microplates And Petri Dishes6/21/2022
Porvair Sciences announce eGecko² – an automated barcode application system that provides the ideal high throughput solution for precisely applying barcode labels onto racks of plates and Petri dishes.
-
New Arm®-Based PIC® Microcontrollers Create An Easier Way To Add Bluetooth® Low Energy Connectivity10/19/2022
Wireless connectivity has become a mandatory feature for many products but often increases the cost and complexity of system design since it generally must be added as part of the larger application.
-
McPhy Signs A Major Contract With Eiffage Énergie Systèmes - Clemessy For A Pioneering Carbon-Free Mobility Project In Belfort1/17/2022
McPhy (Euronext Paris Compartment C: MCPHY, FR0011742329), (the “Company”), specialized in zero-carbon hydrogen production and distribution equipment (electrolyzers and refueling stations), announces that it has signed a contract with Eiffage Énergie Systèmes - Clemessy (acting as agent), a subsidiary of the Eiffage Group, to equip a hydrogen production and distribution site located in Danjoutin, in the south of Belfort in France, operated by Hynamics (hydrogen subsidiary of the EDF Group). Equipped with an electrolyzer and a station, the site will initially be used to fuel low-carbon hydrogen to a fleet of 7 buses operated by the RTTB (“Régie des Transports du Territoire de Belfort”) on behalf of the SMTC (“Syndicat Mixte des Transports en Commun”) on the urban transport network Optymo. Commissioning is expected in spring 2023